Cleared Traditional

K242799 - PliaFX Flo
(FDA 510(k) Clearance)

Nov 2024
Decision
65d
Days
Class 2
Risk

K242799 is an FDA 510(k) clearance for the PliaFX Flo. This device is classified as a Filler, Bone Void, Osteoinduction (w/o Human Growth Factor) (Class II - Special Controls, product code MBP).

Submitted by Lifenet Health (Virginia Beach, US). The FDA issued a Cleared decision on November 21, 2024, 65 days after receiving the submission on September 17, 2024.

This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3045.

Submission Details

510(k) Number K242799 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 17, 2024
Decision Date November 21, 2024
Days to Decision 65 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF

Device Classification

Product Code MBP — Filler, Bone Void, Osteoinduction (w/o Human Growth Factor)
Device Class Class II - Special Controls
CFR Regulation 21 CFR 888.3045

Similar Devices — MBP Filler, Bone Void, Osteoinduction (w/o Human Growth Factor)

All 30
Vivorte Trabexus EB
K143547 · Vivorte, Inc. · Jan 2015
VIVORTE BVF
K130703 · Vivorte, Inc. · Sep 2013
OSTEOSELECT DEMINERALIZED BONE MATRIX PUTTY
K130498 · Bacterin International, Inc. · May 2013
CLEARED UNDER GRAFTON II EDBM
K122513 · Medtronic Sofamor Danek, Inc. · Mar 2013
SURFUSE GEL AND PUTTY, EXFUSE GEL AND PUTTY
K113728 · Hans Biomed Corp. · Nov 2012
ACCELL EVO3 (FORMERLY ACCELL A2I)
K103742 · Integra Life Sciences · Mar 2011